Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina

被引:17
作者
Bettini, Mariela [1 ]
Chaves, Marcelo [1 ]
Cristiano, Edgardo [1 ]
Pagotto, Vanina [1 ]
Perez, Lucia [1 ]
Giunta, Diego [1 ]
Rugiero, Marcelo [1 ]
机构
[1] Hosp Italiano Buenos Aires, Peron 4272, RA-1411 Buenos Aires, DF, Argentina
关键词
Myasthenia; Epidemiology; Incidence; Prevalence; INCREASING INCIDENCE; AUTOANTIBODIES; CANADA;
D O I
10.1159/000477733
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Different epidemiological studies, especially in Europe, have estimated the incidence density of myasthenia gravis (MG) to range between 1.7 and 21.3/1,000,000/person-year; however, data from regions such as Latin America are scarce. This study is aimed at estimating the incidence and prevalence of acquired MG in Buenos Aires, Argentina. Methods: The study population comprised of affiliates of the Italian Hospital Medical Care Program, a prepaid health maintenance organization located in Buenos Aires. The evaluation method for case detection included a retrospective search from January 1, 2006, through December 31, 2012. Results: Of the 60 cases identified, 36 (60%) were females. The median age at diagnosis was 69 years (IQR 51.5-79). The mean age at diagnosis was 63.3 years (SD +/- 20). A total of 28 patients (46.7%) had generalized MG and 32 had ocular MG (53.3%). Thirty five patients (58.3%) had acetylcholine receptor antibodies and 2 (3.3%) had muscle-specific receptor tyrosine kinase antibodies. The crude incidence density (ID) of MG was 61.33 per 1,000,000 person-years (95% CI 47.62-79.99). The adjusted ID for the Argentinean population was 38.8 per 1,000,000 person-years (95% CI 27.09-50.51) and for the Buenos Aires population was 47.49 (95% CI 34.73-60.25). Conclusions: The results obtained are similar to those published for other geographical areas. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:119 / 123
页数:5
相关论文
共 19 条
  • [1] Myasthenia gravis in individuals over 40
    Aarli, JA
    Romi, F
    Skeie, GO
    Gilhus, NE
    [J]. MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 424 - 431
  • [2] LATE-ONSET MYASTHENIA GRAVIS: A REVIEW WHEN INCIDENCE IN OLDER ADULTS KEEPS INCREASING
    Alkhawajah, Nuha M.
    Oger, Joel
    [J]. MUSCLE & NERVE, 2013, 48 (05) : 705 - 710
  • [3] Myasthenia gravis requiring pyridostigmine treatment in a national population cohort
    Andersen, J. B.
    Engeland, A.
    Owe, J. F.
    Gilhus, N. E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (12) : 1445 - 1450
  • [4] Myasthenia gravis -: A higher than expected incidence in the elderly
    Aragonès, JM
    Bolíbar, L
    Bonfill, X
    Bufill, E
    Mummany, A
    Alonso, F
    Illa, I
    [J]. NEUROLOGY, 2003, 60 (06) : 1024 - 1026
  • [5] Belló M, 2011, SALUD PUBLICA MEXICO, V53, pS96
  • [6] Epidemiology of myasthenia gravis in Ontario, Canada
    Breiner, Ari
    Widdifield, Jessica
    Katzberg, Hans D.
    Barnett, Carolina
    Bril, Vera
    Tu, Karen
    [J]. NEUROMUSCULAR DISORDERS, 2016, 26 (01) : 41 - 46
  • [7] A systematic review of population based epidemiological studies in Myasthenia Gravis
    Carr, Aisling S.
    Cardwell, Chris R.
    McCarron, Peter O.
    McConville, John
    [J]. BMC NEUROLOGY, 2010, 10
  • [8] Incidence of myasthenia gravis in the province of Ferrara - A community-based study
    Casetta, I
    Fallica, E
    Govoni, V
    Azzini, C
    Tola, M
    Granieri, E
    [J]. NEUROEPIDEMIOLOGY, 2004, 23 (06) : 281 - 284
  • [9] Myasthenia gravis: a changing pattern of incidence
    Casetta, I.
    Groppo, E.
    De Gennaro, R.
    Cesnik, E.
    Piccolo, L.
    Volpato, S.
    Granieri, E.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 (12) : 2015 - 2019
  • [10] Emilia-Romagna Study Grp Clinical Epidemiologi, 1998, NEUROLOGY, V51, P255